Logo image of ALBOO.PA

BOOSTHEAT SACA (ALBOO.PA) Stock Fundamental Analysis

EPA:ALBOO - Euronext Paris - Matif - FR001400OS22 - Common Stock - Currency: EUR

0.001  0 (-16.67%)

Fundamental Rating

0

Overall ALBOO gets a fundamental rating of 0 out of 10. We evaluated ALBOO against 109 industry peers in the Machinery industry. Both the profitability and financial health of ALBOO have multiple concerns. ALBOO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALBOO had negative earnings in the past year.
ALBOO had negative earnings in each of the past 5 years.
ALBOO had a negative operating cash flow in each of the past 5 years.
ALBOO.PA Yearly Net Income VS EBIT VS OCF VS FCFALBOO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -189.19%, ALBOO is doing worse than 94.50% of the companies in the same industry.
Industry RankSector Rank
ROA -189.19%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALBOO.PA Yearly ROA, ROE, ROICALBOO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K

1.3 Margins

Looking at the Operating Margin, with a value of 37650.00%, ALBOO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Profit Margin and Gross Margin are not available for ALBOO so they could not be analyzed.
Industry RankSector Rank
OM 37650%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALBOO.PA Yearly Profit, Operating, Gross MarginsALBOO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K -20K 40K 60K

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALBOO has more shares outstanding
ALBOO has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALBOO has a worse debt to assets ratio.
ALBOO.PA Yearly Shares OutstandingALBOO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M
ALBOO.PA Yearly Total Debt VS Total AssetsALBOO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 10M 20M 30M

2.2 Solvency

ALBOO has an Altman-Z score of -5.40. This is a bad value and indicates that ALBOO is not financially healthy and even has some risk of bankruptcy.
ALBOO's Altman-Z score of -5.40 is on the low side compared to the rest of the industry. ALBOO is outperformed by 82.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.4
ROIC/WACCN/A
WACCN/A
ALBOO.PA Yearly LT Debt VS Equity VS FCFALBOO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2023 2024 0 10M -10M 20M

2.3 Liquidity

ALBOO has a Current Ratio of 0.31. This is a bad value and indicates that ALBOO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.31, ALBOO is doing worse than 94.50% of the companies in the same industry.
A Quick Ratio of 0.31 indicates that ALBOO may have some problems paying its short term obligations.
With a Quick ratio value of 0.31, ALBOO is not doing good in the industry: 94.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
ALBOO.PA Yearly Current Assets VS Current LiabilitesALBOO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M

0

3. Growth

3.1 Past

ALBOO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.97%, which is quite impressive.
The Revenue for ALBOO has decreased by -92.82% in the past year. This is quite bad
ALBOO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -54.08% yearly.
EPS 1Y (TTM)99.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.88%
Revenue 1Y (TTM)-92.82%
Revenue growth 3Y-37%
Revenue growth 5Y-54.08%
Sales Q2Q%-96.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBOO.PA Yearly Revenue VS EstimatesALBOO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALBOO.PA Yearly EPS VS EstimatesALBOO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 -5M -10M -15M

0

4. Valuation

4.1 Price/Earnings Ratio

ALBOO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBOO.PA Price Earnings VS Forward Price EarningsALBOO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALBOO.PA Per share dataALBOO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALBOO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BOOSTHEAT SACA

EPA:ALBOO (6/3/2025, 7:00:00 PM)

0.001

0 (-16.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)06-09 2025-06-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.9%
Ins Owner ChangeN/A
Market Cap430
Analysts37.14
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.32
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.05
BVpS-8.33
TBVpS-8.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -189.19%
ROE N/A
ROCE -320.43%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 37650%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -5.4
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-92.82%
Revenue growth 3Y-37%
Revenue growth 5Y-54.08%
Sales Q2Q%-96.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y205.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A